Zurich-based startup Ava Science Inc. recently issued a public call for partners and funding to further research the potential usefulness of its fertility wearable, known as Ava Bracelet, during the COVID-19 pandemic.
BOGOTA, Colombia – As the world turns its attention to COVID-19 and its impacts across the globe, in Latin America diseases like Chagas continue to keep scientists busy. In Argentina, researchers are working on an innovative solution to deal with a major threat to the region’s public health.
Beta-O2 Technologies Ltd. plans to enroll its first patients in clinical trials for its second-generation bio-artificial pancreas, ßAir, in the coming months. The small, implantable titanium device has separate components that hold pancreatic cells and a rechargeable oxygen tank. Beta-O2 is based in Rosh-Haayin, Israel.
BOGOTA, Colombia – Ziptek Mexico, from Hermosillo, Mexico, is working to revolutionize the sutures market with an innovative product that is already making its way to the U.S. surgical orthopedic device market. Plans to expand across Latin America are progressing.
Looking to help blind and visually impaired patients, Envision, of The Hague, Netherlands, has unveiled its plans to integrate its artificial intelligence (AI)-powered software technology into Google Glass.
Waveguide Corp. has launched the first portable, battery-powered nuclear magnetic resonance (NMR) device, Waveguide Formμla, offering rapid, on-site screening and diagnostics. The Cambridge, Mass.-based startup is looking to advance the product for use in detecting infectious diseases and cancer.
TORONTO – The head of a of Kitchener, Ontario-based surgical robotics firm has overseen the launch of Canada’s first industry-led hub dedicated to helping med-tech startups commercialize and scale up their technologies and businesses. Intellijoint Surgical Inc. CEO Armen Bakirtzian founded the Medical Innovation Xchange (MIX) for advanced startup companies that understand their markets and have completed initial steps for the design and manufacture of their technology.
TORONTO – Kitchener, Ontario-based Nicoya Life Sciences Inc. has followed up CA$10 million (US$7.6 million) in series A funding raised in January with its launch of “the world’s first digital benchtop surface plasmon resonance (SPR) system” to boost development of drug therapies.
Cambridge, Mass., startup Enclear Therapies Inc. has secured $10 million in series A financing led by 20/20 Healthcare Partners. The company is developing a device to aid in treating amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases by removing toxic proteins from cerebrospinal fluid (CSF).
HONG KONG – Yokneam, Israel-based Serenno Medical Ltd. has unveiled a device for automatic monitoring and detection of kidney damage in patients. Known as Sentinel, the device is a continuous urine output (UO) monitor that measures urine flow rate and volume in real time.